These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 15225897

  • 1. Clinical significance of c-myc and p53 expression in head and neck squamous cell carcinomas.
    Waitzberg AF, Nonogaki S, Nishimoto IN, Kowalski LP, Miguel RE, Brentani RR, Brentani MM.
    Cancer Detect Prev; 2004; 28(3):178-86. PubMed ID: 15225897
    [Abstract] [Full Text] [Related]

  • 2. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
    Nathan CO, Amirghahri N, Rice C, Abreo FW, Shi R, Stucker FJ.
    Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer.
    Edström S, Cvetkovska E, Westin T, Young C.
    Laryngoscope; 2001 Jan; 111(1):124-30. PubMed ID: 11192880
    [Abstract] [Full Text] [Related]

  • 4. Correlation of expression of Ki-67, EGFR, c-erbB-2, MMP-9, p53, bcl-2, CD34 and cell cycle analysis with survival in head and neck squamous cell cancer.
    Smilek P, Dusek L, Veselý K, Rottenberg J, Kostrica R.
    J Exp Clin Cancer Res; 2006 Dec; 25(4):549-55. PubMed ID: 17310847
    [Abstract] [Full Text] [Related]

  • 5. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC, Matheny KE, Westfall MD, Pietenpol JA.
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [Abstract] [Full Text] [Related]

  • 6. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
    Garozzo A, Cutrona D, Palmeri S, Maiolino L, Puzzo L, Allegra E.
    Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157
    [Abstract] [Full Text] [Related]

  • 7. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
    Vielba R, Bilbao J, Ispizua A, Zabalza I, Alfaro J, Rezola R, Moreno E, Elorriaga J, Alonso I, Baroja A, de la Hoz C.
    Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of molecular markers in oral squamous cell carcinoma: a multivariate analysis.
    Shah NG, Trivedi TI, Tankshali RA, Goswami JV, Jetly DH, Shukla SN, Shah PM, Verma RJ.
    Head Neck; 2009 Dec; 31(12):1544-56. PubMed ID: 19424974
    [Abstract] [Full Text] [Related]

  • 9. Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck.
    Farhadieh RD, Smee R, Rees CG, Salardini A, Eggleton S, Yang JL, Russell PJ.
    ANZ J Surg; 2009 Dec; 79(1-2):48-54. PubMed ID: 19183379
    [Abstract] [Full Text] [Related]

  • 10. [Expression of tumor suppressor gene p53 and Rb in patients with epidermoid carcinoma of the head and neck].
    Schipper JH, Kelker W.
    HNO; 1994 May; 42(5):270-4. PubMed ID: 8050915
    [Abstract] [Full Text] [Related]

  • 11. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question.
    Cabanillas R, Rodrigo JP, Astudillo A, Domínguez F, Suárez C, Chiara MD.
    Cancer; 2007 May 01; 109(9):1791-8. PubMed ID: 17380529
    [Abstract] [Full Text] [Related]

  • 12. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
    Akervall J, Bockmühl U, Petersen I, Yang K, Carey TE, Kurnit DM.
    Clin Cancer Res; 2003 May 01; 9(5):1750-5. PubMed ID: 12738730
    [Abstract] [Full Text] [Related]

  • 13. Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death.
    Frederick MJ, Holton PR, Hudson M, Wang M, Clayman GL.
    Clin Cancer Res; 1999 Feb 01; 5(2):361-9. PubMed ID: 10037186
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
    Rodrigo JP, García-Carracedo D, García LA, Menéndez S, Allonca E, González MV, Fresno MF, Suárez C, García-Pedrero JM.
    J Pathol; 2009 Mar 01; 217(4):516-23. PubMed ID: 18991334
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of p53 protein is common in premalignant head and neck lesions.
    Pavelic ZP, Li YQ, Stambrook PJ, McDonald JS, Munck-Wikland E, Pavelic K, Dacic S, Danilovic Z, Pavelic L, Mugge RE.
    Anticancer Res; 1994 Mar 01; 14(5B):2259-66. PubMed ID: 7840533
    [Abstract] [Full Text] [Related]

  • 18. MYC gene amplification reveals clinical association with head and neck squamous cell carcinoma in Indian patients.
    Bhattacharya N, Roy A, Roy B, Roychoudhury S, Panda CK.
    J Oral Pathol Med; 2009 Nov 01; 38(10):759-63. PubMed ID: 19453846
    [Abstract] [Full Text] [Related]

  • 19. Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell.
    Takes RP, Baatenburg de Jong RJ, Schuuring E, Litvinov SV, Hermans J, Van Krieken JH.
    Anticancer Res; 1998 Nov 01; 18(6B):4793-800. PubMed ID: 9891559
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.